IRIS
TORNIAI, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.468
EU - Europa 474
AS - Asia 157
AF - Africa 17
Totale 2.116
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.468
IT - Italia 106
UA - Ucraina 87
IE - Irlanda 77
SE - Svezia 75
SG - Singapore 51
DE - Germania 48
CN - Cina 42
TR - Turchia 39
DK - Danimarca 25
FI - Finlandia 25
CI - Costa d'Avorio 17
KR - Corea 15
BE - Belgio 14
GB - Regno Unito 14
IN - India 9
FR - Francia 1
JP - Giappone 1
LT - Lituania 1
RU - Federazione Russa 1
Totale 2.116
Salva come PNG Salva come JPEG
Città #
Chandler 218
Fairfield 139
Ashburn 134
Jacksonville 131
Des Moines 113
Dublin 77
Wilmington 73
Woodbridge 58
New York 56
Seattle 54
Houston 51
Cambridge 49
Ann Arbor 37
Boardman 36
Lawrence 31
Princeton 31
Turin 31
San Mateo 30
Abidjan 17
Singapore 17
Brussels 14
San Diego 14
Washington 14
Los Angeles 13
Helsinki 11
Centro 10
Falls Church 9
Pune 9
Beijing 7
Norwalk 7
Kilburn 6
Shanghai 6
Guangzhou 3
Jiaxing 3
London 3
Montegiorgio 3
Castelraimondo 2
Chengdu 2
Cupra Marittima 2
Hounslow 2
Porto 2
Shenzhen 2
Wuxi 2
Ancona 1
Bevagna 1
Cernusco sul Naviglio 1
Chiswick 1
Chizhou 1
Foligno 1
Genoa 1
Mondolfo 1
New Bedfont 1
Quanzhou 1
Redwood City 1
San Severino Marche 1
Sano 1
Seoul 1
Trecastelli 1
Wuhan 1
Totale 1.545
Salva come PNG Salva come JPEG
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 88
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 87
Electrolyte disorders in cancer patients: a systematic review 85
Gender differences and outcome of melanoma patients 83
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 81
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 80
Hyponatremia in cancer patients: Time for a new approach 79
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 79
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 77
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 77
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 76
Gender Differences and Outcomes in Melanoma Patients 76
Benefits and limitations of a multidisciplinary approach in cancer patient management 76
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 72
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 71
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 70
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 69
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 69
Systemic treatment for lung carcinoids: from bench to bedside 68
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 67
High CTLA-4 expression correlates with poor prognosis in thymoma patients 67
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 66
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 65
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 65
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 63
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 60
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 60
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 58
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study 52
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 49
Medical Treatment in Gastroenteropancreatic Neuroendocrine Neoplasms: a look into the future. 40
Totale 2.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020142 0 0 14 2 16 0 15 0 18 13 18 46
2020/2021551 36 50 80 24 67 32 27 45 55 51 48 36
2021/2022246 16 36 14 3 7 30 11 12 28 24 25 40
2022/2023666 40 78 42 58 30 165 0 35 128 4 70 16
2023/2024359 51 6 31 22 48 107 7 25 1 14 1 46
2024/202551 51 0 0 0 0 0 0 0 0 0 0 0
Totale 2.175